Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | OXTR | P30559 | 1/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10111087 | 0.97 | HPGD (0.48) | SMN1; SMN2HPGDAVPR1AGLAOXTR | |
| SCHEMBL10110916 | 0.90 | SMN1; SMN2 (0.50) | SMN1; SMN2HPGDAVPR1AGLAOXTR | |
| SCHEMBL14026401 | 0.88 | UCHL3 (0.46) | SMN1; SMN2HPGDAVPR1AGLAOXTR | |
| SCHEMBL10110923 | 0.88 | HSD11B1 (0.56) | SMN1; SMN2HPGDAVPR1AGLAOXTR | |
| SCHEMBL10111086 | 0.87 | SMN1; SMN2 (0.46) | SMN1; SMN2HPGDAVPR1AGLAOXTR | |
| SCHEMBL10111046 | 0.86 | HPGD (0.51) | SMN1; SMN2HPGDAVPR1AGLAOXTR | |
| SCHEMBL10110929 | 0.86 | SMN1; SMN2 (0.46) | SMN1; SMN2HPGDAVPR1AGLAOXTR | |
| SCHEMBL14315635 | 0.85 | MAPT (0.42) | SMN1; SMN2AVPR1AKDM4EMAPTL3MBTL1 | |
| SCHEMBL10111093 | 0.85 | HSD11B1 (0.56) | SMN1; SMN2HPGDAVPR1AGLAOXTR | |
| SCHEMBL13368077 | 0.84 | KDM4E (0.50) | SMN1; SMN2HPGDALDH1A1KDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10790451-B2 | Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2020-09-29 | — | — | US | disclosed |
| US-20160268515-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LAB (JP) | 2016-09-15 | — | — | US | disclosed |
| US-9397299-B2 | Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-20140042420-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-02-13 | — | — | US | disclosed |
| US-20120199818-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-08-09 | — | — | US | disclosed |
| US-8178217-B2 | 4-(4-bromophenyl)-3,5-diphenyl-4H-1,2,4-triazole; high triplet excitation energy; high luminous efficiency, low power consumption | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-15 | — | — | US | disclosed |
| WO-2008143019-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-11-27 | — | — | WO | disclosed |
| US-20080286607-A1 | Triazole derivative, and light-emitting device, and electronic device with the use of triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120199818-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | TYR, TH, YEATS4 | SMN1; SMN2 4821/4885HPGD 2021/4885AVPR1A 4243/4885 |
| US-20160268515-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | TYR, TH, YEATS4 | SMN1; SMN2 4821/4885HPGD 2021/4885AVPR1A 4243/4885 |
| US-10790451-B2 | Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative | TYR, TH, YEATS4 | SMN1; SMN2 4821/4885HPGD 2021/4885AVPR1A 4243/4885 |
| US-20080286607-A1 | Triazole derivative, and light-emitting device, and electronic device with the use of triazole derivative | TYR, TH, CYP3A4 | SMN1; SMN2 4814/4885HPGD 1695/4885AVPR1A 4259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.